What are the differential diagnoses for primary male infertility?

Differential Diagnoses for Primary Male Infertility

Primary male infertility has three major diagnostic categories: obstructive azoospermia, non-obstructive azoospermia (spermatogenic failure), and abnormal semen parameters with sperm present (oligozoospermia, asthenozoospermia, teratozoospermia). 1

Algorithmic Approach to Differential Diagnosis

Step 1: Semen Analysis Classification

Obtain at least 2 semen analyses one month apart to account for biological variability 1. Based on results:

If Azoospermia (No Sperm in Ejaculate)

After centrifugation and microscopic examination confirms true azoospermia 1, differentiate between:

A. Obstructive Azoospermia - characterized by:

• Normal testicular size on physical examination
• Bilaterally dilated/indurated epididymides with or without absent vas deferens
• FSH <7.6 IU/L (normal spermatogenesis occurring but blocked)
• Normal semen pH (>7.0) if proximal obstruction
• Low volume (<1.4 mL) + acidic pH (<7.0) = distal obstruction (CBAVD or ejaculatory duct obstruction) 1

Specific causes:

• Congenital bilateral absence of vas deferens (CBAVD)
• Ejaculatory duct obstruction (EDO)
• Post-infectious epididymal obstruction
• Post-vasectomy
• Iatrogenic injury

B. Non-Obstructive Azoospermia (Spermatogenic Failure) - characterized by:

• Testicular atrophy (small, soft testes)
• FSH >7.6 IU/L (hypergonadotropic hypogonadism)
• Normal semen volume and pH 1

Specific causes requiring genetic testing:

• Klinefelter syndrome (47,XXY most common; 48,XXXY or 49,XXXXY in severe cases)
• Y-chromosome microdeletions (found in 5% of men with sperm concentration 0-1 million/mL) 1
• Robertsonian translocations and other structural chromosomal anomalies
• Maturation arrest
• Sertoli cell-only syndrome
• Cryptorchidism sequelae
• Chemotherapy/radiation effects
• Idiopathic spermatogenic failure

If Oligozoospermia (Sperm Concentration <16 million/mL)

Severe oligozoospermia (<5 million/mL) warrants:

• Karyotype testing when accompanied by elevated FSH, testicular atrophy, or impaired sperm production 1
• Y-chromosome microdeletion testing (0.8% prevalence in 1-5 million/mL range) 1

Causes include:

• Varicocele (most common correctable cause)
• Partial obstruction
• Hormonal abnormalities (hypogonadotropic hypogonadism)
• Genetic abnormalities (as above)
• Medications/toxins
• Systemic illness
• Idiopathic

If Asthenozoospermia (Progressive Motility <30%)

Causes include:

• Primary ciliary dyskinesia
• Antisperm antibodies
• Partial obstruction with epididymal dysfunction
• Varicocele
• Infection/inflammation
• Oxidative stress
• Idiopathic

If Teratozoospermia (Normal Morphology <4%)

Causes include:

• Varicocele
• Genetic defects affecting sperm structure
• Oxidative stress
• Idiopathic

Step 2: Hormonal Assessment

Measure testosterone, LH, and FSH in all infertile men 1:

• Low testosterone + low/normal LH/FSH = Hypogonadotropic hypogonadism (pituitary/hypothalamic dysfunction)
• Low testosterone + elevated LH/FSH = Primary testicular failure
• Normal testosterone + elevated FSH = Isolated spermatogenic failure
• High testosterone + elevated LH = Androgen resistance

Step 3: Genetic Testing Indications

Mandatory genetic testing for:

• Azoospermia with elevated FSH, testicular atrophy, or suspected impaired sperm production → Karyotype 1
• Severe oligozoospermia (<5 million/mL) with elevated FSH or testicular atrophy → Karyotype 1
• Azoospermia or severe oligozoospermia with suspected spermatogenic failure → Y-chromosome microdeletion testing 1
• CBAVD → CFTR mutation testing (cystic fibrosis gene)

Step 4: Additional Diagnostic Considerations

Aspermia (no ejaculate):

• Retrograde ejaculation (check post-ejaculatory urine)
• Ejaculatory duct obstruction
• Neurologic dysfunction
• Medications (alpha-blockers, antipsychotics)

Normozoospermia with infertility:

• Sperm DNA fragmentation
• Antisperm antibodies
• Female factor predominant
• Coital dysfunction

Critical Pitfalls to Avoid

1. Never rely on a single semen analysis - biological variability is substantial 1
2. Do not skip genetic testing in severe oligozoospermia or azoospermia - these conditions can be transmitted to offspring via ICSI 1
3. Low volume + acidic pH mandates evaluation for CBAVD/EDO - missing this delays appropriate genetic counseling 1
4. FSH level of 7.6 IU/L is the critical threshold for distinguishing obstructive from non-obstructive causes 1
5. Point-of-care/mail-in tests are insufficient for comprehensive evaluation - specialized andrology laboratory testing is mandatory 1